Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (436)	6/20/2002 1:06:22 PM
From: Jibacoa	Read Replies (1) of 544

INGN Is now also on the red column after the initial rise. Apparently the news on the patent were not good enough in spite of the comments on Forbes and the Biotech.Valuation thread.<g> Message 17628761 Introgen's mda-7 Gene Therapeutic Receives Patent AUSTIN, Texas, June 20 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN - News) and The Trustees of Columbia University announced today that the United States Patent and Trademark Office has issued ...... siliconinvestor.com The latest downtrend started in late April. siliconinvestor.com Will see if the support at 2 (which seems to be an important one <g> )will hold. siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next